SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Value of Lifestyle Intervention to Prevent Diabetes and Sequelae
12 references·0 citing·44 second hop
Value of Lifestyle Intervention to Prevent Diabetes and Sequelae (2014)Value of Lifestyle Intervention to Preven…Cost of a Group Translation of the Diabetes Prevention Program (2013)Cost of a Group Translation o…The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention (2012)The 10-Year Cost-Effectivenes…Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1 (2012)Modeling Good Research Practi…Health Utility Scores for People With Type 2 Diabetes in U.S. Managed Care Health Plans (2012)Health Utility Scores for Peo…Long‐Term Trends in Medicare Payments in the Last Year of Life (2010)Long‐Term Trends in Medicare …Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis (2010)Age at initiation and frequen…Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis (2008)Different strategies for scre…'Computer modeling of diabetes and its complications: A report on the Fourth Mount Hood Challenge Meeting' (2007)'Computer modeling of diabete…A National Catalog of Preference-Based Scores for Chronic Conditions in the United States (2005)A National Catalog of Prefere…The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making (2004)The CORE Diabetes Model: Proj…A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) (2004)A model to estimate the lifet…Costs Associated With the Primary Prevention of Type 2 Diabetes Mellitus in the Diabetes Prevention Program (2003)Costs Associated With the Pri…Cost-Effectiveness in Health and Medicine (1996)Within-Trial Cost-Effectiveness of Lifestyle Intervention or Metformin for the Primary Prevention of Type 2 Diabetes (2003)A causal modelling approach to the development of theory-based behaviour change programmes for trial evaluation (2005)The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance (2005)Economic Costs of Diabetes in the U.S. in 2007 (2008)Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force (2015)The Cost of Diabetes Care—An Elephant in the Room (2018)Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review (2020)Estimating Utility Values for Health States of Type 2 Diabetic Patients Using the EQ-5D (UKPDS 62) (2002)Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial (2008)Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions (2011)EuroQol - a new facility for the measurement of health-related quality of life (1990)Methods for the Economic Evaluation of Health Care Programmes (2005)Catalogue of EQ-5D Scores for the United Kingdom (2011)Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) (2011)Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study (2012)Theory of games and economic behavior (2019)Economic Consequences of Diabetes Mellitus in the U.S. in 1997 (1998)Proceedings of the 2004 Winter Simulation Conference, 2004. (2004)Projecting the Future Diabetes Population Size and Related Costs for the U.S. (2009)State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3 (2012)Valuing Health-Related Quality of Life in Diabetes (2002)Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes (2005)Preference-Based EQ-5D Index Scores for Chronic Conditions in the United States (2006)Screening for Diabetes and Prediabetes Should Be Cost-Saving in Patients at High Risk (2013)Does Diversity Matter for Health? Experimental Evidence from Oakland (2019)Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008? (2020)The Medicare Payment Advisory Commission. (1998)Medical Spending of the US Elderly (2016)Predictive modeling of U.S. health care spending in late life (2018)Envisioning a Better U.S. Health Care System for All: Coverage and Cost of Care (2020)Probabilistic Sensitivity Analysis Using Monte Carlo Simulation (1985)Markov Models in Medical Decision Making (1993)Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies (2003)Utilities and disutilities for attributes of injectable treatments for type 2 diabetes (2010)Review of Utility Values for Economic Modeling in Type 2 Diabetes (2014)Simulation Modeling and Analysis. (1983)Simulation modeling and analysis (1999)Decision Modelling For Health Economic Evaluation (2006)Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6 (2012)Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force (2013)Economic Evaluation of Lifestyle Interventions for Preventing Diabetes and Cardiovascular Diseases (2010)Projecting the direct cost burden of osteoarthritis in Canada using a microsimulation model (2015)Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge (2018)
this work references cited by second hop

References

  • 2012Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1767 cited
  • 2004A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)615 cited
  • 2004The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making528 cited
  • 2010Long‐Term Trends in Medicare Payments in the Last Year of Life443 cited
  • 2012The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention435 cited
  • 2005A National Catalog of Preference-Based Scores for Chronic Conditions in the United States388 cited
  • 2003Costs Associated With the Primary Prevention of Type 2 Diabetes Mellitus in the Diabetes Prevention Program358 cited
  • 2008Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis290 cited
  • 2010Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis286 cited
  • 2007'Computer modeling of diabetes and its complications: A report on the Fourth Mount Hood Challenge Meeting'199 cited
  • 2012Health Utility Scores for People With Type 2 Diabetes in U.S. Managed Care Health Plans110 cited
  • 2013Cost of a Group Translation of the Diabetes Prevention Program55 cited

Cited by

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

No citing works inside the corpus for this window.